BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,088,446 | -20.2% | 134,829 | -3.6% | 0.02% | -17.2% |
| Q2 2023 | $6,373,890 | +21.0% | 139,901 | +7.7% | 0.03% | +3.6% |
| Q1 2023 | $5,268,947 | -15.3% | 129,905 | +6.4% | 0.03% | -22.2% |
| Q4 2022 | $6,224,202 | -1.6% | 122,115 | +4.0% | 0.04% | -10.0% |
| Q3 2022 | $6,323,000 | -57.8% | 117,390 | -49.7% | 0.04% | -56.5% |
| Q2 2022 | $14,984,000 | -16.8% | 233,280 | +0.4% | 0.09% | -6.1% |
| Q1 2022 | $18,015,000 | -9.9% | 232,328 | -0.3% | 0.10% | -3.0% |
| Q4 2021 | $19,997,000 | +13.2% | 232,962 | +6.1% | 0.10% | +1.0% |
| Q3 2021 | $17,660,000 | +22.0% | 219,570 | +22.1% | 0.10% | +19.0% |
| Q2 2021 | $14,473,000 | +69.9% | 179,789 | +78.0% | 0.08% | +55.6% |
| Q1 2021 | $8,521,000 | +8.6% | 101,026 | +3.3% | 0.05% | +1.9% |
| Q4 2020 | $7,848,000 | +4.8% | 97,800 | +5.1% | 0.05% | -7.0% |
| Q3 2020 | $7,485,000 | -38.0% | 93,074 | -33.7% | 0.06% | -44.1% |
| Q2 2020 | $12,079,000 | +10.4% | 140,306 | +4.1% | 0.10% | -9.7% |
| Q1 2020 | $10,946,000 | 0.0% | 134,815 | +3.0% | 0.11% | +15.3% |
| Q4 2019 | $10,946,000 | -4.3% | 130,903 | +0.1% | 0.10% | -10.1% |
| Q3 2019 | $11,443,000 | +9.6% | 130,821 | +2.7% | 0.11% | +5.8% |
| Q2 2019 | $10,436,000 | -3.3% | 127,412 | -4.0% | 0.10% | -2.8% |
| Q1 2019 | $10,788,000 | +24.7% | 132,676 | +0.9% | 0.11% | +9.3% |
| Q4 2018 | $8,652,000 | -10.4% | 131,443 | +4.9% | 0.10% | +3.2% |
| Q3 2018 | $9,660,000 | +7.3% | 125,312 | +2.8% | 0.09% | +1.1% |
| Q2 2018 | $9,002,000 | -26.3% | 121,910 | -35.0% | 0.09% | -30.1% |
| Q1 2018 | $12,207,000 | +3.4% | 187,681 | +2.8% | 0.13% | -2.9% |
| Q4 2017 | $11,805,000 | +52.6% | 182,628 | +48.1% | 0.14% | +37.0% |
| Q3 2017 | $7,737,000 | +40.9% | 123,294 | +36.0% | 0.10% | +35.1% |
| Q2 2017 | $5,490,000 | +18.3% | 90,684 | +1.4% | 0.07% | +13.8% |
| Q1 2017 | $4,639,000 | +19.7% | 89,453 | +2.4% | 0.06% | -7.1% |
| Q4 2016 | $3,875,000 | +27.8% | 87,393 | +37.2% | 0.07% | +29.6% |
| Q3 2016 | $3,032,000 | +8.9% | 63,693 | +3.4% | 0.05% | +3.8% |
| Q2 2016 | $2,785,000 | -4.4% | 61,593 | -13.1% | 0.05% | -5.5% |
| Q1 2016 | $2,912,000 | +13.1% | 70,893 | +5.1% | 0.06% | +10.0% |
| Q4 2015 | $2,574,000 | -68.5% | 67,463 | -72.9% | 0.05% | -69.5% |
| Q3 2015 | $8,174,000 | -54.0% | 248,823 | -2.1% | 0.16% | -50.2% |
| Q2 2015 | $17,778,000 | -8.7% | 254,230 | -10.5% | 0.33% | -5.2% |
| Q1 2015 | $19,468,000 | -26.2% | 284,195 | -21.0% | 0.35% | -24.7% |
| Q4 2014 | $26,362,000 | -7.4% | 359,687 | -9.9% | 0.46% | -8.3% |
| Q3 2014 | $28,473,000 | +1.0% | 399,138 | +3.0% | 0.50% | -3.5% |
| Q2 2014 | $28,194,000 | -13.0% | 387,422 | -12.3% | 0.52% | -12.1% |
| Q1 2014 | $32,422,000 | +84.1% | 441,522 | +74.4% | 0.59% | +87.7% |
| Q4 2013 | $17,608,000 | +76.2% | 253,156 | +66.4% | 0.32% | +67.2% |
| Q3 2013 | $9,993,000 | -17.3% | 152,130 | -12.8% | 0.19% | -20.9% |
| Q2 2013 | $12,082,000 | – | 174,411 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |